As 5‑MeO‑DMT draws buzz, scientists and conservationists warn against “toad milking.” Here’s what’s known, what’s not, and how DMV readers should approach it.

Journalist Erica Rex urges caution: psychedelic states can open trauma and power imbalances. Here’s what ethical care, safety, and patient-centered practices should look like in the DMV.

Safety, ethics, dosage, vape pens, and the ibogaine combo—what 5‑MeO‑DMT actually demands, and how DMV readers should navigate it without hype.

A high-profile 5-MeO-DMT facilitator faces hard scrutiny—plus Oregon policy shifts, a notorious mushroom strain, and more. Here’s the culture impact and the DMV angle.

A plain-language guide to 5‑MeO‑DMT—the “God Molecule”—covering effects, risks, early research, legality, and what DC, Maryland, and Virginia residents should know now.

Discover the legal battles, scientific testing disputes, and regulatory developments surrounding the Church of Sacred Synthesis sacrament.

Psychedelic Alpha spotlights Kimon de Greef’s look at 5‑MeO‑DMT’s ascent from Sonora to pharmaceutical interest. Here’s what DMV readers should watch and why it matters.

New federal signals and Big Pharma interest set the stage as Horizons comes back to New York. Here’s what DMV residents should watch, and how policy, access, and culture may evolve next.

FDA guidance, Phase 3 results and VA-led training signal psychedelic therapies edging closer to clinics. Here’s what practitioners—and DMV patients—should know now.

A new biography reveals how fabricated Indigenous lineage created a persistent blueprint for exploitation in the psychedelic underground.

An Emory-led consortium is recruiting 800 adults in the US, Canada, and Australia for a first-of-its-kind study on difficulties that persist after psychedelic experiences.